to see how well the therapy of AK117/placebo combined with Azacitidine fights Higher-risk Myelodysplastic Syndrome and how safe it is.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
United States (Nationwide)
Joshua Zeidner
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
24-0365